• Rapidly growing cannabis market evolving to include diverse clientele seeking unique strains
• PACR uses genetics-first approach to cultivate exclusive high-yield strains with varying cannabinoid profiles
• PACR catalog features 350 tested cultivars, including 50 super-elite strains prized for unique properties

Smoking marijuana decades ago traditionally meant rolling one type of cannabis that was grown outdoors under mostly natural conditions. Decades later, the market has completely transformed to accommodate the needs of savvy consumers who understand different strains and their varying effects. PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated to producing premium-quality strains and products through a genetics-focused approach, is positioned to benefit from this market shift with roughly 350 tested cultivars in its extensive catalog, which includes 50 super-elite strains prized throughout the industry for their unique therapeutic properties. Marijuana strains are typically differentiated by their color, smell, taste and cannabinoid profile – the latter being the phytochemical composition specific to the plant. Specialized cultivation and strain development is undertaken by many growers seeking to leverage specific properties of the plant in order to produce specialized strains for specific markets—markets which include both medical and recreational users. The result of this innovation in cannabis cultivation has been a boom in branded cannabis strains, evidenced by increased brand recognition among loyal, repeat customers at legal dispensaries (https://ibn.fm/iq8Ca). PACR is positioned to benefit from these emerging markets by providing retailers with high-quality strains tailored for specific uses. The company’s genetics-based approach to cultivation has produced prized strains with varying amounts of tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”) – two of over 140 known cannabinoids in the cannabis plant that can produce different effects on the body. Along with altering the cannabinoid profile of its strains, the company also leverages genetic technology to develop plants that thrive in different climatic conditions for maximum yields each season. PACR has a competitive advantage in the industry through its strategic licensing agreement with Phenome One Corp, a privately-held full-service genetics cannabis company that gives PACR access to one of the largest living genetic cannabis libraries in Canada. This valuable, unparalleled resource has enabled the Company to diversify its product catalog to include hundreds of cultivars and dozens of elite strains offering specialized beneficial characteristics unique to the market. The cannabis market has evolved from small-time dealers on street corners to an entire industry with differentiated products and discerning, knowledgeable consumers. PACR is leveraging this market shift through a genetic-first approach to cultivation that produces first-in-class high-yield strains which appeal to a wide variety of consumers across the rapidly growing legal cannabis market. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing  and has  after
• Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter
• The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both the white and blue light images side-by-side simultaneously on the surgical monitor
• Bladder cancer is the sixth most prevalent cancer in the U.S., the third most common cancer in men, more than 17,000 deaths are expected in the U.S. this year due to bladder cancer
• Once Imagin obtains final FDA approval and finishes rolling out its product, the company expects to expand its product line by adapting its IP for use with multiple contrast agents for use in other minimally invasive surgeries

Following an unusual series of hardships for North America, as well as the world at large, during the past year, people are beginning to see reasons for optimism that 2021 will deliver better economic news, less political unrest and an overall reversal of the COVID pandemic’s persistently climbing death and disability toll.

Imagin Medical (CSE: IME) (OTCQB: IMEXF), has achieved significant milestones during 2020 despite the obstacles posed by COVID and other adverse factors. Imagin’s strategy has positioned the company for greater strides in the coming year as socio-economic conditions improve.

Imagin’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’’ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. A key feature is the system’s adaptability to almost any scope already in use by hospitals and surgical centers.

But the company was compelled to cut salaries and reduce expenses in all areas of the business during 2020 in order to extend its financial runway for duration of the pandemic, while also transitioning to online meeting technology that better enabled Imagin to safeguard the health and wellbeing of its employees.

Despite the difficulties, Imagin was able to transition its product from the development stage to manufacturing — contracting with Lighthouse Imaging, an FDA registered and ISO 13485:2016-certified manufacturer. The contract will help propel Imagin toward completion of its final pre-production stage and finalize test parameters that meet exacting FDA requirements for live-use surgical imaging equipment., according to a news release issued by the company (https://ibn.fm/Th7Nr).

“Our relationship with Lighthouse Imaging marks a new stage in the company’s progress,” Imagin President and CEO Jim Hutchens stated. “We anticipate 2021 to be a breakout year with emphasis on manufacturing and the FDA process.”

The product preparation for broad manufacturing, as well as FDA approval and marketing procedures, will be funded largely by a $3 million convertible note undertaken by Imagin during the final months of 2020. The company has closed on the first of four tranches and expects to execute the final tranche this quarter, according to the news release.

Imagin will also work to develop expanding support from the medical community, in part through its participation at the 2021 American Urology Association (“AUA”) annual meeting. Imagin considers the AUA conference to be very significant marketing and networking opportunity that, much to their frustrations, was cancelled last year due to the pandemic (https://ibn.fm/gvrX1).

Imagin’s current technological approach is to help combat bladder cancer during minimally invasive surgery with advanced imaging abilities. Bladder cancer is the fourth most common cancer in men and one that is expected to directly result in more than 17,000 deaths this year in the United States, with similar numbers expected for 2021 (https://ibn.fm/R864t). Providing more precise visualization than white light, blue light cystoscopy infuses the bladder with a contrast agent that highlights the contours of the cancer. To resect, however, surgeons must use the real-time white light image, requiring them to switch back and forth to locate and then remove the cancer. The i/Blue Imaging System provides the option to display, in real-time, the white and blue light images side-by-side simultaneously, eliminating the need to switch back and forth resulting in a more efficient and effective procedure.

Eventually, Imagin expects to expand its IP for use with other contrast agents and minimally invasive surgeries, such as laparoscopic (general and gynecological), colorectal and thoracic interventions.

For more information, visit the company’s website at www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• UME commited to offering high-quality COVID-19 services, solutions and supplies.
• To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical.
• CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers.

Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes the infectious disease, is likely here for the long haul (https://ibn.fm/1idh8). United Medical Equipment Business Solutions Network (“UME”) is here for the long haul too, commited to offering high-quality COVID-19 services, solutions and supplies. Among the supplies UME currently provides is the CareStart(TM) COVID-19 Antigen Rapid POC test.

Before COVID-19 was even declared a pandemic, the CareStart COVID-19 Antigen test had been authorized for use by the Federal Drug Administration (“FDA”) under an Emergency Use Authorization (“EUA”). “Due to the highly contagious nature and global spread, SARS-CoV-2 . . . continues to have devastating impacts on healthcare systems and the world economy, including the U.S.,” states CareStart COVID-19 Antigen packaging material approved by the FDA (https://ibn.fm/BIVxs).

“To effectively end the SARS-CoV02 pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical,” the information continues. “Particularly, the identification of subclinical or asymptomatic cases is important to reduce or stop the infection because these individuals may transmit the virus. As a point-of-care test with a 10 min testing time, CareStartCOVID-19 Antigen test allows effective screening of COVID-19 infection on a large scale.”

The CareStart antigen test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen (https://ibn.fm/qCkqU). The innovative test features a 10-minute processing time, identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike.

The CareStart product is part of a UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance of medical experts and includes ongoing, data-driven COVID-19 testing. United Medical Equipment Business Solutions is committed to being the leading provider of high-quality, reliable and transparent information and resources for all, particularly veterans and seniors. The company provides essential information and products that helps the community achieve optimal health and improve their quality of life.

In addition to the CareStart COVID-19 Antigen tests, UME provides a wide array of other COVID-19 supplies and products, including sanitizers, gloves and face shields, thermometers, hoods and masks.

UMEs’ mission is to provide guidance for caregivers, veterans, the aging population and the medical community through its robust medication management and telehealth applications. In addition, the company recognizes the importance of being socially responsible as a corporation by giving back to the world through emergency assistance grants awarded to seniors, with an emphasis on veterans, by supporting nonprofits in their missions, and by supporting the American economy by providing work-at-home opportunities.

To learn more about this company, visit www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

• Autonomous Security Robot (“ASR”) maker Knightscope offers a Machine-as-a-Service (“MaaS”) subscription that monitors, records and relays information according to business client needs
• Knightscope’s AI-enhanced robots patrol sites for Fortune 1000 companies, hospitals and police department clients, providing a sense of safety particularly in crime-prone areas
• The robots’ security features include 360-degree eye-level HD streaming video, obstacle recognition, face and license plate recognition, and thermal anomaly detection
• The Knightscope Security Operations Center (“KSOC”) allows operators to monitor real-time data produced by the robot patrols and to communicate with people through the robots’ Intercom and Broadcast system if necessary
• Market analysts foresee the ASR market growing with a CAGR of 7.93 percent between 2021 and 2026

Cautious optimism is driving economic forecasts for 2021 in the United States as market managers anticipate improving economic data and bullish investor sentiment but also the risks of a bumpy transition year if new COVID-19 pandemic containment policies stifle growth or pandemic-driven economic safety nets are terminated before the general public is ready to progress without them (https://ibn.fm/sQX21). Patient business leaders will continue to plan for their companies’ safety needs while hoping for the best possible outcomes of vaccine rollout efforts, a new national political administration and evidence that societal upheaval is prompting a recommitment to day-to-day stability measures. Autonomous robot manufacturer Knightscope is working to play a key role in making the United States a more secure place. Knightscope’s product platform involves a lineup of AI-driven patrols that can help companies manage transitions in workforce levels and reduce crime in areas affected by destabilization. The company’s products include robot sentries for a variety of business conditions. One robot monitors from a stationary platform while two other models rove the premises, designed for indoor or outdoor conditions as needed. The robots are designed to recognize obstacles in their path as they move about, but also potential obstacles to a safe environment for employees. They can provide alerts to business visitors about COVID policies, optional temperature scanning for fevers, landscape and perimeter inspection, and recordings of faces and license plates filmed with 360-degree live video. Clients have reported effective problem deterrence when using Knightscope’s Autonomous Security Robots (“ASRs”). A recent blog entry provided a few examples: One hospital network reported it was experiencing an average of two crimes per week. When a mobile ASR was deployed, the crime rate dropped to zero for the following 12 months. When a California police department introduced an ASR to a crime-prone public park, officers saw a 46 percent reduction in crimes and a 68 percent drop in citations. And when a San Francisco business deployed a robot in its parking structure, crimes dropped from an average of 20 per month to one over the course of 12 months (https://ibn.fm/p7Csy). The robots are delivered on a Machine-as-a-Service (“MaaS”) business model that features subscriptions with annual contracts. The robots operate 24 / 7 every day with an effective price of $4 to $11 per hour (https://ibn.fm/4qR9h). They are capable of recharging themselves at strategically located stations when their battery level begins to drop, and their Knightscope Security Operations Center (“KSOC”) allows operators to gain access to information in real-time circumstances. The global autonomous mobile robots market size is expected to reach $145.5 billion by 2026, rising at a market growth of 24.6 percent CAGR during that period, according to a recent report by ResearchAndMarkets.com (https://ibn.fm/u8qY3). Mordor Intelligence analysts anticipate that between 2020 and 2026, revenues for the global ASR market segment will rise from $2.44 billion to $3.91 billion, with a CAGR between 2021 and 2026 of 7.93 percent (https://ibn.fm/obKX1). For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• Friendable Inc.’s Fan Pass platform attracted a roster of more than 700 artists in 2020
• Fan Pass is filling the void created by the live event shutdown necessitated by the COVID-19 pandemic
• New subscribers can check out the latest updates and releases from their favorite artists for free on a trial basis by downloading the Fan Pass app

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, kicked off the new year by issuing a recap of its milestones and achievements in 2020. In the news release, the company noted that artist sign ups for its innovative Fan Pass platform, which connects artists with fans through exclusive virtual channels, surpassed 700 last year. This total marked a significant ramp up following Friendable’s launch of the Fan Pass platform in late July 2020 with a debut event featuring 16 performers. “In a very short period of time following our release of Fan Pass we have continued to receive numerous items of validation while continuing to test new traction points, service offerings and scalability of our business model,” Robert A. Rositano Jr., CEO of Friendable, stated in the news release (https://ibn.fm/ua6la). “As we are focused on providing the very best experience for our artists and their fans, these spikes validate many of our efforts while providing additional and significant exposure for our brand.” The Fan Pass platform’s focus on live streaming and virtual events filled a sizable need in recent months as the entertainment industry has struggled to navigate and survive the sustained effects of the worldwide pandemic. The global live events sector has seen its income all but erased since March 2020, and this industry-wide shutdown is expected to continue well into 2021 (https://ibn.fm/muraw). In the absence of live events, concerts and gatherings, Fan Pass has provided an effective alternative ecosystem through which diehard followers and casual fans alike can support and develop lasting connections with a growing collection of artists. For artists, Fan Pass provides a number of advantages, particularly as the worldwide live entertainment market remains extremely limited. The platform’s intuitive design allows artists to invite fans and social followers from around the world to join in exclusive chats and experience virtual VIP meetups, interviews and behind-the-scenes content. The platform even allows artists to offer custom-designed merchandise to their growing fanbases. “We are very excited for 2021, as the live streaming video marketplace continues to lead the way into an entirely new model of in-person live events combined with the live, yet virtual, experience of performing on Fan Pass,” Rositano continued. “This is a year for scale on all fronts as we are confident our revenues will continue to scale as we perform, per our plan.” Fan Pass is free for new subscribers on a trial basis and is currently available for download on both the App Store and Google Play. Following the trial, subscriptions are billed at $3.99 per month, providing exclusive access to artists and their latest projects at a fraction of the cost of traditional face-to-face meetups. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Company acquired seven gold projects in the mineral-rich Andes Mountains of Northern Chile, with three ready for drilling
• Epithermal deposits signify additional nearby and/or deeper strains of porphyry deposits
• Canada, Chile have maintained strong, stable relationship for nearly 80 years

The Canadian junior exploration company GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) has, in 2020, acquired low-risk, high-quality land in its search for new deposits of gold. As the company moves into 2021, new projects and phases of exploration are in the works.

As a junior gold mining company, GoldHaven has its eye on the price of gold and the jurisdictions’ stability with every project undertaken. The ability to read the market and navigate the fluctuations of the economy is essential. As a new undertaking, not bringing the right skill to the table on day one is a disaster waiting to happen. The GoldHaven team brings a wealth of experience and knowledge from having successfully worked within the mining industry and holding high-level positions in publicly traded mining companies; company executives have more than 100 years of combined experience in gold mining.

The goal of GoldHaven is to funnel that combined talent and expertise into projects that provide stability and de-risk the investment. To succeed, GoldHaven must identify and capitalize on valuable precious metal projects in mineral-rich districts within stable political jurisdictions.

In 2020, GoldHaven acquired seven gold projects located in the Maricunga Gold Belt in Northern Chile. To date, this mineral-rich land is known to host over 100 million oz. of gold, 450 million oz. of silver, and 13 billion lbs. of copper in resources (https://ibn.fm/Yu6Y7).

Gold mining in Chile dates back to the end of the 16th century. The current Chilean gold rush is due to the discovery of a series of subvolcanic gold deposits. These deposits, which are mainly epithermal, have mostly been found at elevations over 4,000 m in the Andean Cordillera, also known as the Andes Mountains (https://ibn.fm/eru0u). Epithermal deposits provide around 12% of the world’s annual gold production, the presence of which also indicates additional porphyry deposits nearby and at a greater depth (https://ibn.fm/gdTe3).

The Maricunga Belt lies between latitudes 26 degrees and 28 degrees south in the Andes of Northern Chile. According to the BBC, “Chile is one of South America’s most stable and prosperous nations. It has been relatively free of the coups and arbitrary governments that have blighted the continent” (https://ibn.fm/mvrm5).

Canada has had a close relationship with Chile for close to 80 years. The two countries share values that include democracy, human rights, open markets and more. The Canada-Chile Partnership Framework and the Canada-Chile Free Trade Agreement (“CCFTA”) have allowed companies such as GoldHaven to explore minerals and metals’ sustainable development. Chile is Canada’s top investment destination in South and Central America. Direct investment in Chile reached $21.5 billion at the end of 2018 (https://ibn.fm/TUWnG). It is a relationship that only continues to grow stronger and more stable with time.

While 2020 has proven to be a year of uncertainties, GoldHaven has risen to the challenge and navigated exploration and development with a talented management team. With the combined expertise of a seasoned team, mineral-rich projects, and assets in stable political jurisdictions, GoldHaven continues to offer security during uncertain times to investors.

For more information, visit the company’s website at www.GoldHavenResources.com.

NOTE TO INVESTORS: The latest news and updates relating to GHVNF are available in the company’s newsroom at http://ibn.fm/GHVNF

• First-Mover Advantage:PlantX maintains a first-mover advantage as the first (known) public company fully focused on the plant-based e-commerce space
• Strong Execution:PlantX has strong business fundamentals. The company is well-capitalized with cash on the balance sheet, no debt, low CapEx requirements and diverse revenue streams
• Discounted to Peers:For the month of December 2020, PlantX achieved a gross revenue of $1,029,883. PlantX is strongly positioned against public plant-based peers, who are trading at much higher revenue multiples
• High-Growth Sectors:PlantX’s operates in three high-growth industries – the plant-based, e-commerce/technology and consumer-packaged goods sectors. PlantX plans to fill the void in the marketplace by bridging the gap between these investment opportunities
• Organic Growth & Strategic M&A:The company plans to grow organically through new partnerships, global brick-and-mortar locations and additional product verticals, as well as through a pipeline of accretive M&A opportunities
• Global Positioning:The move for PlantX is global, and the intent to list on Nasdaq evidences PlantX’s commitment to investor accessibility and corporate growth

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more. PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including: An easy-to-use e-commerce shopping experience featuring the following:

• Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
• Meal delivery with recipes created by well-known plant-based chefs throughout the world
• Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
• Easy to follow plant-based recipes every week
• Partnerships with restaurants, nutritionists, chefs and brands
• A community of like-minded individuals
• State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home. Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community. The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). Market Outlook With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020. Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%. PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries. Digital Platform for the Plant-Based Community The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings. PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

• Shop
• Find recipes
• Read blogs
• Join a community forum
• Listen to podcasts
• View cosmetics
• Research vitamins
• Purchase plant-based pet foods
• Read corporate updates
• Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine. PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition. These PlantX branded flagship locations will first launch in:

• Squamish, British Columbia, Canada
• San Diego, California, United States
• Tel Aviv, State of Israel

Customer engagement, education and creating a global plant-based community will be furthered through this initiative. PlantX Restaurant Partnerships With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier. PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus. Future Goals for PlantX Life Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel. Verticals launched in 2020 include:

• New meals and programs by renowned chefs
• Flagship PlantX locations
• PlantX branded goods
• United States meal delivery and LIV
• Online peer-to-peer fitness

Management Team Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk. Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles. Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception. Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts. For more information, visit the company’s website at www.PlantX.com. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• The proposed allocation of these funds is in alignment with investee PowerTap’s plans to begin rollout of its hydrogen fueling stations network in the second half of the year
• PowerTap will generate additional revenue to finance its hydrogen infrastructure by participating in the California Low Carbon Fuel Standard Carbon credit program
• Hydrogen fueling adoption advocate and auto racing entrepreneur George Steinbrenner IV is appointed to PowerTap’s advisory board, will bring his commitment to sustainability and influence to help promote company’s hydrogen production and dispensing technology

Investment holding company Clean Power Capital (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) welcomed a California proposal to allocate $1.5 billion to the construction and maintenance of charging and hydrogen fueling infrastructure. According to a company press release, California Governor Gavin Newsom’s proposal to earmark these funds as part of a $4.5 billion stimulus proposal for the 2021 state budget is encouraging for Clean Power Capital and its investee PowerTap’s hydrogen station plans (https://ibn.fm/5cToG).

PowerTap Hydrogen Fueling Corp is currently preparing to roll out its initial hydrogen fueling stations nationwide in the second half of 2021 and will soon announce its partners for this stage, CEO Raghu Kilambi said. He also explained that the $1.5 billion stimulus for hydrogen infrastructure is in alignment with the company’s own plans and supports its aggressive rollout strategy.

The company plans to deploy its hydrogen fueling infrastructure at existing truck stops and gas stations across the country, with an initial roll-out of up to 500 stations. All of PowerTap’s hydrogen stations will adhere to the California Governor’s Office of Business and Economic Development permitting guidebook.

Additionally, PowerTap also intends to participate in the California Low Carbon Fuel Standard (LCFS) Carbon credit program, one of the most innovative carbon emission credit trading plans, which will offer the company the opportunity to generate revenue by selling earned LCFS credits on the emission trading markets before it even begins dispensing hydrogen through its planned fueling station infrastructure (https://ibn.fm/hjTcd).

Participation in the LCFS program will provide PowerTap with more revenue to finance its hydrogen station infrastructure. Moreover, with the change in U.S. administration, the company is optimistic that the U.S. federal government will launch new green initiatives that will include funding and incentives for the hydrogen infrastructure space, Kilambi explained.

To help PowerTap further advance and commercialize its hydrogen production and dispensing technology, Clean Power Capital has appointed auto racing entrepreneur George Steinbrenner IV to its investee’s advisory board (https://ibn.fm/ZNUpu).

A staunch supporter of different earth-friendly avenues and policies and promoter of various charitable programs, Steinbrenner is the youngest team owner in the NTT INDYCAR Series. His commitment to sustainability both in his personal life and business practices is fully in line with INDYCAR’s planned move to implement single-source hybrid systems as of 2023. Steinbrenner has long supported the message of sustainability in the field of motorsport via unique initiatives such as helping implement comprehensive recycling programs, implementing green power at campsites and trying to achieve a carbon neutral or overall better transportation footprint by running an alternative fuel transporter and companion generator.

“Expanding our relationships and participation within sustainability opens long-term benefit. As our team and series continue to innovate, aligning with growth-minded companies such as PowerTap that naturally connect to existing partnerships within the biofuels space opens mutual benefit opportunities,” Steinbrenner said. “I’m excited to take an advisory role within PowerTap and welcome applying their industry-leading technologies and strategic partnerships to bring greater adoption.”

Kilambi also welcomed the appointment, voicing appreciation for Steinbrenner’s clean energy focus and active involvement in the auto racing industry as an active advocate of hydrogen fueling adoption. “Mr. Steinbrenner’s industry relationships and influence will be critical as PowerTap launches the commercialization of our onsite hydrogen production and dispensing technology,” the PowerTap CEO added.

With its impressive portfolio of IP and advanced deployed technologies, as well as plans to build and expand a hydrogen filling station network across North America, PowerTap was an attractive opportunity for Clean Power Capital Corp., an investment company focused on identifying lucrative opportunities in the health and renewable energy industries. Clean Power Capital has 10 investments in various sectors and currently holds 90 percent equity interest in PowerTap Hydrogen Fueling.

For more information, visit the company’s website at www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

• Company shares update of biopesticide product pipeline
• MGROF committed to combating deadly crop diseases, pests in Colombia and North America
• MustGrow touts potential additional uses as bioherbicide, sprout suppressor

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops and other markets, recently provided an update of its biopesticide product pipeline (https://ibn.fm/eOTGT). By extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — the company has provided natural solutions to potentially replace widely used harmful synthetics that are being banned and deregistered.

As part of the update, the company reported that a U.S. EPA registration already exists for its biopesticide product in granule format for use as a preplant soil treatment for high-value crops such as fruits and vegetables. The company is now working to obtain a new registration for its biopesticide in liquid format. As with the granular biopesticide, the liquid format is also made from food-grade mustard and has the same active ingredient: AITC. The new liquid biopesticide will be called TerraMG, and MustGrow is anticipating EPA approvals this year.

TerraMG has proved effective in the control of clubroot, a disease destroying Canada’s canola crop, in laboratory and greenhouse. Clubroot spores travel easily, and currently no effective solution exists to control the disease in infected fields. Farmers have had to take extreme precautionary measures to protect against the disease; those measures include crop rotation and seeking resistant varieties of canola. Once a field is infected with clubroot, it can lead to 100% crop loss. With initial efficacy trials completed in both laboratory and greenhouse facilities, MustGrow is working to replicate the same results in field studies (https://ibn.fm/63aqj).

Canada isn’t the only country set to benefit from MustGrow’s biopesticide technology. In 2019 Colombia declared a national state of emergency due to Fusarium wilt TR4, also referred to as the Panama disease. This devastating pathogen has ravaged the $25 billion global banana industry. MustGrow has accomplished something the company believes no other agriscience team has yet to achieve: 100% control of Fusarium wilt TR4 in laboratory. Further testing will determine if the patented biopesticide technology will control the disease in field settings (https://ibn.fm/KhB2B).

As the world shifts to safer more sustainable products, synthetic herbicides face high-profile legal and regulatory challenges. The need for bioherbicides is increasing. MustGrow is using its natural mustard-derived biological approach to address this need. In the laboratory, after only 72 hours, herbicidal control was achieved using MustGrow’s products. This success led to the filing of patents for MustGrow bioherbicides. Moving forward, the company will continue to focus testing on hard to kill and herbicide-resistant weeds (https://ibn.fm/sAtJ2).

In addition to in-field application as a biopesticide and bioherbicide of MustGrow’s mustard-derived technology, MustGrow is also looking at post-harvest application for food preservation and disease and pest control. On Oct. 8, 2020, chlorpropham (“CIPC”), the leading agrochemical product for sprout suppression, was banned by the EU. With no effective treatment alternatives, potato storage sites have a major problem. MustGrow is working to create a solution and has announced an exclusive patent licensing from the University of Idaho (https://ibn.fm/Rj0bv). The mustard-derived biopesticides the company uses rely on a natural sprout inhibitor that does not contain synthetic chemicals associated with negative human health consequences.

The global biopesticide market continues to grow as the world makes the shift to ban or deregister synthetic chemicals. According to Markets and Markets, the industry is expected to double, reaching $8.5 billion by 2025. MustGrow’s safe and effective signature products hold the potential to disrupt global agriculture markets traditionally dominated by synthetic chemicals.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• GRYN positioning itself for rapid growth in 2021
• Retaining expert counsel with innate understanding of cannabis law is necessary step as company builds highly differentiated business model
• Green Hygienics’ growth strategy includes rollout of omnichannel bricks-and-clicks program featuring multiple premium brands

As Green Hygienics Holdings (OTCQB: GRYN) wraps up its first successful crop harvest and enters the wholesale retail stage of development, the company has engaged the services of McAllister Garfield, PC, a top law firm in the industrial hemp space. GRYN, an innovative technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, made the decision in anticipation of rapid growth in 2021. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to be ahead of the curve and thrive,” said Green Hygienics CEO Ron Loudoun. “Navigating regulatory compliance in an emerging industry is no small task, but a very important one to our company, and retaining counsel of such an established law firm with an innate understanding of cannabis law is a necessary step as we build out our highly differentiated business model.” In addition to retaining McAllister Garfield, part of Green Hygienics’ strategy for growth includes the rollout of an omnichannel bricks-and-clicks program featuring multiple premium brands layering over different market segments in the hemp industry. GRYN’s partnership with McAllister Garfield will provide insight and expertise in navigating regulatory compliance issues. The firm will also provide invaluable advice and support throughout the rollout, including assistance with retail opportunities. Specifically, GRYN is working with McAllister Garfield to obtain three business licenses in the downtown vicinity of San Diego for the following:

• a hemp-centric coffee house
• a smoking lounge
• An all-things-hemp dispensary and storefront

“We are pleased to be working with Green Hygienics Holdings, Inc., a promising company which puts a focus on compliance and consumer safety,” said McAllister Garfield’s hemp/CBD chairman David Wunderlich. “McAllister Garfield provides sophisticated business advice lending guidance on foundational documents, mergers and acquisitions, transactional and employment law, litigation, and administrative regulatory enforcement. Our team of lawyers has been present in the hemp industry from the very beginnings and offers a suite of solutions helping our clients through to positive outcomes as they run the regulatory gauntlet.” Green Hygienics is committed to consistently delivering safe, premium-quality products to consumers; the company is also looking to partner with CPG (consumer-packaged-goods) and pharmaceutical companies in its mission to offer hemp-based products that consumers are searching for. GRYN is focused on becoming a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. In addition, GRYN is exploring the full range of novel cannabinoids and targeted bio-delivery technologies with the objective of solving issues of stability, pharmacokinetics, biological tissue penetration and bioavailability. The company has assembled a team of visionary agrotechnology, pharmaceutical, and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with the mission to improve lives. For more information, visit the company’s website at www.GreenHygienics.com. NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN